CRISPR Insider™

CRISPR News and Information from Around The World

Science sub-issue heavy research:the use of CRISPR to correct the entire gene to treat Duchenne muscular dystrophy!

Posted by btwatson on February 5, 2018 4:21 am
Tags:
Categories: Baidu

Source: Science sub-issue heavy research:the use of CRISPR to correct the entire gene to treat Duchenne muscular dystrophy!

[unable to retrieve full-text content]

bio Valley in 2018 02 months 03 days 08:49

2018 2 3 news /bio Valley BIOON /–a United States and Germany, the multinational research team published a study by the newCRISPRthe technical use of the Duchenne muscular dystrophy(DMD) The patient’s pluripotent stem cells to produce healthy myocardial tissue research… Baidu snapshot

(RSS generated with FetchRss)
Published at Mon, 05 Feb 2018 04:05:33 +0000

Leave a Reply Cancel reply

You must be logged in to post a comment.

< CRISPR Insider™ home

Crispr News

  • Readout Newsletter: Biotech news, Wall Street disappointment ... - STAT
    October 3, 2023
  • Intellia, Regeneron to take CRISPR collaboration outside the liver with revised deal - FierceBiotech
    October 3, 2023
  • The Democratization of Gene-Editing and the Odin DIY Kit - Nasdaq
    October 3, 2023
  • Regeneron and Intellia expand collaboration to develop CRISPR ... - Investing.com
    October 3, 2023
  • Crispr Genomic Cure Market: Moving Towards a Brighter Future | An ... - Digital Journal
    October 3, 2023
  • Regeneron and Intellia Announce Expanded Research ... - Bluefield Daily Telegraph
    October 3, 2023
  • Repare Therapeutics to Host Conference Call and Webcast to ... - InvestorsObserver
    October 3, 2023
  • Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately ... - The Motley Fool
    October 3, 2023
  • Genome Engineering Market Research Report With Qualitative and ... - Digital Journal
    October 3, 2023
  • Sharper and Smaller – Tiny CRISPR Tool Could Help Shred Viruses - SciTechDaily
    October 3, 2023
  • Emerging Players and Innovative Technologies Transform the Landscape of Allogeneic CAR Cell Therapy Market - Yahoo Finance
    October 2, 2023
  • 5 FDA decisions to watch in the fourth quarter - BioPharma Dive
    October 2, 2023
  • Art imitates science - ASBMB Today
    October 2, 2023
  • Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics - Nasdaq
    October 2, 2023
  • Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics - The Motley Fool
    October 2, 2023
  • CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
    CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
  • CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
  • The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
    The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
  • The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
  • ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
    ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
  • The Dark Side of CRISPR – Scientific American
    The Dark Side of CRISPR – Scientific American
  • ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
    ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
  • Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
    Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
  • DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
    DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
  • CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
    CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
  • Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
    Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
  • New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
    New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
  • After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
    After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
  • Load more [+]

Copyright 2020 CrisprInsider.com